PURESEOUL to Make East Midlands Debut with Leicester Highcross Store
Why It Matters
The store taps the surging UK demand for K‑beauty, strengthening PURESEOUL’s foothold in a key regional market and boosting Highcross’s draw for trend‑focused shoppers.
Key Takeaways
- •PURESEOUL opens 163.4 m² store at Highcross Leicester in early May.
- •Store brings K‑beauty brands Torriden, Milktouch, Medicube, Sungboon to East Midlands.
- •Expansion follows successful Birmingham Bullring launch in autumn 2024.
- •Highcross reintroduces Office retailer with 313.49 m² store in April.
Pulse Analysis
The Korean beauty wave has reshaped UK skincare, with consumers chasing the coveted "glass skin" look. Brands like Torriden and Milktouch have become household names, driving retailers to seek dedicated spaces. PURESEOUL, a curated multi‑brand concept, capitalises on this trend by offering a boutique experience that bundles premium products under one roof, appealing to both enthusiasts and newcomers.
Leicester’s Highcross mall, positioned near the city centre and anchored by fashion and jewellery retailers, provides an ideal launchpad. The 163.4 m² unit on the lower mall benefits from high footfall and proximity to Ernest Jones, creating cross‑shopping opportunities. By entering the East Midlands, PURESEOUL taps a market that demonstrated strong support during its Birmingham rollout, signalling confidence in regional growth potential.
Beyond PURESEOUL, Highcross’s decision to bring back Office in a larger 313.49 m² space underscores a broader retail strategy: diversifying the tenant mix to capture lifestyle spending. As K‑beauty continues to dominate beauty conversations, other malls may follow suit, prompting a wave of specialty beauty concepts. For investors and industry watchers, the Leicester opening serves as a bellwether for how niche beauty retailers can scale through strategic mall partnerships while meeting evolving consumer preferences.
PURESEOUL to make East Midlands debut with Leicester Highcross store
Comments
Want to join the conversation?
Loading comments...